MADE appoints Wonderhood Studios as European creative agency
Calculus portfolio company Wonderhood Studios will be working with MADE to help creatively bring to life the brand’s vision, giving it a fresh and bold point of view
Calculus portfolio company Wonderhood Studios will be working with MADE to help creatively bring to life the brand’s vision, giving it a fresh and bold point of view
Important note: Past performance is not indicative of future performance. Tax benefits depend on the individual circumstances of each investor and may be subject to change in the future. Welcome to our first update of 2022. The run up to the tax year end is always a busy time and this year has been no … Continued
Calculus VCT has invested into Destiny Pharma, a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention.
Invizius Awarded Major Biomedical Catalyst Grant to bring Anti-Inflammatory Haemodialysis Treatment to The Clinic
Arecor Granted Key U.S. Patent Protecting Proprietary Insulin Products, AT247 and AT278.
genedrive plc announces that the first six installations of the Antibiotic Induced Hearing Loss system have been deployed to Manchester University NHS Foundation Trust
Calculus Capital is looking to appoint a Chief Operating Officer. The individual will support the CEO in implementing organisational vision and operational strategy.
Calculus Capital is looking for someone to fill the role of Fund Admin Analyst.
Netflix has ordered Brouhaha Entertainment’s adaptation of Trent Dalton’s Boy Swallows Universe, more than two years after publisher HarperCollins announced it had sold the screen rights to the author’s debut novel.
MIP Diagnostics, a UK nanotechnology business has secured increased investment of its previous round of funding, totalling £7.3M. The joint investment comes from Mercia Asset Management, Calculus Capital, Downing Ventures and BGF, along with an original angel investor.